Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evaluation of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Subjects With Rosacea.

Autor: Nelson JM; Dermatology, University of Michigan, Ann Arbor, USA., Rizzo JM; Dermatology, The Woodruff Institute for Dermatology, Bonita Springs, USA., Greene RK; Dermatology, University of Michigan, Ann Arbor, USA., Fahlstrom K; Dermatology, University of Michigan, Ann Arbor, USA., Troost JP; Biostatistics, Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, USA., Helfrich YR; Dermatology, University of Michigan, Ann Arbor, USA., Nakamura M; Dermatology, University of Michigan, Ann Arbor, USA.

Publikováno v: Cureus [Cureus] 2024 Oct 25; Vol. 16 (10), pp. e72363. Date of Electronic Publication: 2024 Oct 25 (Print Publication: 2024).

A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases.

Autor: Novice T; University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA., Kariminia A; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, Canada., Del Bel KL; Department of Pediatrics, BC Children's Hospital Research Institute, Vancouver, Canada., Lu H; Department of Pediatrics, BC Children's Hospital Research Institute, Vancouver, Canada., Sharma M; Department of Pediatrics, BC Children's Hospital Research Institute, Vancouver, Canada., Lim CJ; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, Canada., Read J; Department of Pediatrics, Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA., Lugt MV; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA., Hannibal MC; Division of Pediatric Genetics, Metabolism & Genomic Medicine, Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA., O'Dwyer D; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA., Hosler M; Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, MI, USA., Scharnitz T; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA., Rizzo JM; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA., Zacur J; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA., Priatel J; Department of Pediatrics, BC Children's Hospital Research Institute, Vancouver, Canada., Abdossamadi S; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, Canada., Bohm A; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, Canada., Junker A; Division of Clinical Immunology & Allergy, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada., Turvey SE; Division of Clinical Immunology & Allergy, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada., Schultz KR; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, Canada.; Division of Pediatric Hematology/Oncology and Bone Marrow Transplant, Department of Pediatrics, BC Children's Hospital, University of British Columbia, 4480 Oak Street, Vancouver, Canada., Rozmus J; Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital Research Institute, Vancouver, Canada. jrozmus@cw.bc.ca.; Division of Pediatric Hematology/Oncology and Bone Marrow Transplant, Department of Pediatrics, BC Children's Hospital, University of British Columbia, 4480 Oak Street, Vancouver, Canada. jrozmus@cw.bc.ca.

Publikováno v: Journal of clinical immunology [J Clin Immunol] 2020 Feb; Vol. 40 (2), pp. 267-276. Date of Electronic Publication: 2019 Dec 19.

VISTA is an acidic pH-selective ligand for PSGL-1.

Autor: Johnston RJ; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA, USA. robert.johnston@bms.com., Su LJ; Selection Technologies and Protein Engineering, Bristol-Myers Squibb, Cambridge, MA, USA., Pinckney J; Biomolecular Characterization, Bristol-Myers Squibb, Cambridge, MA, USA., Critton D; Molecular Structure and Design, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Boyer E; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Krishnakumar A; Proteomics Discovery, Bristol-Myers Squibb, Hopewell, NJ, USA., Corbett M; Protein Sciences, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Rankin AL; Immuno-Oncology Discovery, Five Prime Therapeutics, South San Francisco, CA, USA., Dibella R; Selection Technologies and Protein Engineering, Bristol-Myers Squibb, Cambridge, MA, USA., Campbell L; Selection Technologies and Protein Engineering, Bristol-Myers Squibb, Cambridge, MA, USA., Martin GH; genOway, Lyon, France., Lemar H; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Cayton T; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Huang RY; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Deng X; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Nayeem A; Molecular Structure and Design, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Chen H; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Ergel B; Protein Sciences, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Rizzo JM; Protein Sciences, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Yamniuk AP; Protein Sciences, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Dutta S; Biomolecular Characterization, Bristol-Myers Squibb, Cambridge, MA, USA., Ngo J; Translational Sciences, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Shorts AO; Translational Sciences, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Ramakrishnan R; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Kozhich A; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Holloway J; Translational Bioinformatics, Bristol-Myers Squibb, Redwood City, CA, USA., Fang H; Lead Discovery and Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Wang YK; Lead Discovery and Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Yang Z; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA., Thiam K; genOway, Lyon, France., Rakestraw G; Selection Technologies and Protein Engineering, Bristol-Myers Squibb, Cambridge, MA, USA., Rajpal A; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Sheppard P; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Quigley M; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Bahjat KS; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA, USA., Korman AJ; Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.; Vir Biotechnology, San Francisco, California, USA.

Publikováno v: Nature [Nature] 2019 Oct; Vol. 574 (7779), pp. 565-570. Date of Electronic Publication: 2019 Oct 23.

Metastatic melanoma with diffuse melanosis histologically after stable response to talimogene laherparepvec therapy.

Autor: Rizzo JM; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan., Fecher LA; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan.; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan., Chan MP; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan.; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan., Durham AB; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan.

Publikováno v: JAAD case reports [JAAD Case Rep] 2018 Apr 04; Vol. 4 (4), pp. 379-381. Date of Electronic Publication: 2018 Apr 04 (Print Publication: 2018).